FilingIndex
10-KThe Record

Avalo Therapeutics, Inc. files 10-K

Filed Apr 2, 2018 · 8y ago · Accession 0001628280-18-003890

Plain English

Annual report — full-year financials, business overview, and risk factors.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
AVTX
CIK
1534120
Form type
10-K
Filing date
Apr 2, 2018
Report date
Dec 31, 2017
Document
cerc10-k20171231.htm
Size
10.9 MB